

















User account | Camber Capital Management, LLC






investor@cambercapital.com
Camber Capital Management, LLC

        101 Huntington Avenue, Suite 2101  
        Boston, MA 02199
      






Username: *
 Enter your Camber Capital Management, LLC username.


Password: *
 Enter the password that accompanies your username.






Forgot Your Password?
          | Account Help



          2017 © Camber Capital.
          By logging into this website, you agree to the terms and conditions of the Terms of Use




















CAMBER CAPITAL MANAGEMENT LLC Institutional Portfolio - NASDAQ.com






























































Hot Topics:
ETFs |
Smart Portfolio |
Currencies |
Online Broker Center















Search






















Home > 
	Quotes > 
	Ownership & Insider Trades > 
    Institutional Portfolio






CAMBER CAPITAL MANAGEMENT LLC






101 HUNTINGTON AVENUE, BOSTON,  Massachusetts, 02199, (617) 717-6600


Report Date: 03/31/2017

Position Statistics


Total Positions
35


New Positions
4


Increased Positions
10


Decreased Positions
14


Positions with Activity
24


Sold Out Positions
7


Total Mkt Value (in $ millions)
1,889



Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.



Sector Weighting



Energy



Basic Materials



Industrials



Consumer Cyclicals



Consumer Non-Cyclicals



Financials



Healthcare
100%


Technology



Telecommunication Services



Utilities










Total Positions




New




Increased




Decreased




Activity




Sold Out






35 Positions as of 03/31/2017


Company

Class

Value of Shares ($1,000s) ▼

Change in Value ($1,000s)

Change (%)

Shares Held



TEVA PHARMACEUTICAL INDS LTD
SPONSORED ADR
172,352
16,256
10.41
5,216,450


MYLAN N V
SHS EURO
162,477

New
4,145,889


GILEAD SCIENCES INC
COM
140,961
29,676
26.67
1,900,000


NEKTAR THERAPEUTICS
COM
124,848
-13,872
(10)
5,400,000


ALLERGAN PLC
SHS
111,617
-27,472
(19.75)
435,750


VERTEX PHARMACEUTICALS INC
COM
106,223
-16,342
(13.33)
650,000


MYRIAD GENETICS INC
COM
102,676
6,291
6.53
4,325,000


SELECT MED HLDGS CORP
COM
82,750
-16,964
(17.01)
5,000,000


GENOMIC HEALTH INC
COM
81,117

New
2,458,100


BROOKDALE SR LIVING INC
COM
78,100

New
5,500,000


LIVANOVA PLC
SHS
74,460

New
1,200,000


BIOVERATIV INC
COM
69,795
64,243
1,157.14
1,100,000


ORTHOFIX INTL N V
COM
68,370

New
1,500,000


PUMA BIOTECHNOLOGY INC
COM
61,945
61,945
New
650,000


PERRIGO CO PLC
SHS
61,617
-30,496
(33.11)
808,200


SAREPTA THERAPEUTICS INC
COM
57,294
57,294
New
1,350,000


ENDO INTL PLC
SHS
57,138
13,007
29.47
5,052,000


CARDIOVASCULAR SYS INC DEL
COM
56,368
-24,158
(30)
1,750,000


ABBOTT LABS
COM
50,400

New
1,000,000


ALKERMES PLC
SHS
41,738
-15,832
(27.5)
725,000




<< first< previous12next >last >>








Latest News Headlines




                            Heritage Commerce Corp Declares Quarterly Cash Dividend of $0.10 Per Share
                        



	                     6:22PM ET  - GlobeNewswire
	                




                            Heritage Commerce Corp Reports Record Earnings of $7.4 Million for the Second Quarter 2017
                        



	                     6:21PM ET  - GlobeNewswire
	                




                            EURO Ressources :80% Increase in Reserves at Rosebel Mine Concession
                        



	                     6:20PM ET  - GlobeNewswire
	                




                            Meta Financial Group, Inc.® Announces Non-Renewal of H&R Block Agreement for 2018
                        



	                     6:15PM ET  - GlobeNewswire
	                




                            BMC Software ends merger talks with peer CA -sources
                        



	                     5:59PM ET  - Reuters
	                





View All Latest Headlines



































CLOSEX

Edit Favorites

Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.






Update

Clear List







CLOSEX
Customize your NASDAQ.com experience
Background Color Selector

Select the background color of your choice:





 Black
							





 Slate Gray
							






 Light Gray
							





 Gray Blue
							






Quote Search

Select a default target page for your quote search:



						 Real-Time

						 After Hours

						 Pre-Market
 News
					


						 Flash Quote

						 Summary Quote

						 Interactive Charts

						 Default Setting




					Please note that once you make your selection, it will apply to all future visits to NASDAQ.com.
					If, at any time, you are interested in reverting to our default settings, please select Default Setting above.
					
					If you have any questions or encounter any issues in changing your default settings, please email isfeedback@nasdaq.com.
				





CLOSEX
Please confirm your selection:

					You have selected to change your default setting for the Quote Search. This will now be your default target page;
					unless you change your configuration again, or you delete your
					cookies. Are you sure you want to change your settings?


YES
NO













CLOSEX


Please disable your ad blocker (or update your settings to ensure that javascript and cookies are enabled), so that we can continue to provide you with the first-rate market news and data you've come to expect from us.





CLOSEX




































Camber Capital Management LLC: Private Company Information - Bloomberg









































  





















































































July 27, 2017 6:24 PM ET
Capital Markets

Company Overview of Camber Capital Management LLC



Snapshot People




Company Overview
Camber Capital Management LLC is a privately owned hedge fund sponsor. The firm primarily provides its services to pooled investment vehicles. It also manages accounts for individuals. The firm invests in the public equity and hedging markets of the United States. It invests in value stocks of micro-cap and small-cap companies. The firm typically invests in health care sector. It employs a fundamental analysis with a bottom-up stock picking approach while making its investments. Camber Capital Management LLC was founded on February 9, 2006 and is based in Boston, Massachusetts.


101 Huntington AvenueSuite 2550Boston, MA 02199-8089United StatesFounded in 2006



Phone: 617-717-6600

Fax: 617-717-6688

www.cambercapital.com







Key Executives for Camber Capital Management LLC




Mr. Stephen Rodney Du Bois


      	Founder and Portfolio Manager
      








Mr. Sean George


      	Chief Financial Officer
      








Mr. Brian James Foley


      	Chief Operating Officer
      








Mr. Douglas Fraser Maclean


      	Chief Compliance Officer
      





Compensation as of Fiscal Year 2017. 

Camber Capital Management LLC Key Developments

Camber Capital To Review Investment In Sequenom 
Mar 24 16
Camber Capital Management LLC says after acquiring 14.54% stake in Sequenom Inc. (NasdaqGS:SQNM) that it intend to review the investment in the Company on a continuing basis and may engage in discussions with management, the Company’s Board of Directors, other shareholders of the Company and other relevant parties in order to enhance shareholder value. Such discussions aimed at enhancing shareholder value may concern, among other things, potential business combinations and strategic alternatives, and the business, operations, governance, management, strategy and future plans of the Company. 


Similar Private Companies By Industry



Company Name
Region



 @Visory LLC United States 1 Road Partners LLC United States 11T Partners, LLC United States 123Jump.com, Inc. United States 1509225 Ontario, Inc. United States




Recent Private Companies Transactions



TypeDate
Target





Merger/Acquisition

			      November 17, 2016
			    
Universal American Corp.





Request Profile Update

















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



Most Searched Private Companies



Company Name
Geographic Region



 Lawyers Committee for Civil Rights Under Law United States NYC2012, Inc. United States The Advertising Council, Inc. United States Bertelsmann AG Europe Rush University United States













Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Camber Capital Management LLC, please visit www.cambercapital.com.  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close






























Camber Capital Management Llc in Boston, MA 02116 - ChamberofCommerce.com




   =     


        









Sign Up
Sign In
Contact Us


 














Search
 

near
 













Home
» Massachusetts
» Boston
» Arts & Entertainment
» Camber Capital Management Llc













Camber Capital Management Llc


0 Reviews

0.0000 stars - based on 0 reviews
                            





575 Boylston st Ste 4R  Boston, Massachusetts 02116


(617) 224-1759
Website


 



 

Print |
                Save |
                Directions


About
Camber Capital Management Llc is located at the address 575 Boylston st Ste 4R in Boston, Massachusetts 02116.  They can be contacted via phone at (617) 224-1759 for pricing, hours and directions.  Camber Capital Management Llc has an annual sales volume of 1M – 1,999,999.  .For more information contact ADAM  MIKKELSON, Analyst or  go to www.cambercapital.comCamber Capital Management Llc provides Individual Services, Long Term Planning, Banking to it's customers.  For maps and directions to Camber Capital Management Llc view the map to the right.  For reviews of Camber Capital Management Llc see below.









Business Features

PRODUCTS


Mutual Funds
, Loans
, IRAs
, Government Securities
, Stocks
, Rollover Plans
, Tax Free Investments
, Mortgage Investments
, CDs
, Corporate Bonds



SERVICES


Banking
, Long Term Planning
, Individual Services
, Charitable Giving
, Cash Management
, Consultations
, Income Planning
, Family Wealth Planning



 


Information

CONTACT INFORMATION
Phone: (617) 224-1759
Website: www.cambercapital.com
ADDITIONAL INFORMATION:
Employee Size: 1 To 4
Exact Employee Count: 3
Exact Sales Volume: 610000
Location Type: Single Location
Sales Volume: 1M – 1,999,999
CATEGORIES:


Arts & Entertainment
Investment Banking & Securities Dealers & Brokers
Finance
Investments & Securities



People Also Viewed


Neshv


17 Court St  Boston, Massachusetts 02108




Jacoby Photography


108 Mount Vernon St  Boston, Massachusetts 02108




J P Morgan Investor Svc Co


73 Tremont st Fl 11 # 11 Boston, Massachusetts 02108




IDS Trading Inc


333 Washington St Ste 643 Boston, Massachusetts 02108




BOSTON CHOWDA CO


800 Boylston St Fc005 Ste Boston, Massachusetts 02199




Preservation Of Affrdbl Hsng


153 Milk St  Boston, Massachusetts 02109





Reviews

Add


You must Sign in to post reviews.





by  on 






Click here to be the first to review this business...



0 Reviews
 


Key Contacts




Adam  Mikkelson
ANALYST
Phone: 617733 187 
 



 























 






Site Map
FAQ
Privacy Policy
Terms of Use
About
Partners
Chamber Partner Program
Chamber Member Benefits




Top Cities:
Atlanta
Bronx
Brooklyn
Chicago
Cleveland
Dallas
Denver
Detroit
Houston
Las Vegas
Los Angeles
Miami
Minneapolis
New York
Philadelphia
Phoenix
Saint Louis
San Antonio
San Diego
San Jose


© 2017 CHAMBEROFCOMMERCE.COM










      Stephen Dubois - Camber Capital Management - 2017 Stock Picks and Performance - Insider Monkey                          Companies 0 See All     Hedge Funds 0 See All    Insiders 0 See All    Institutional Investors 0 See All   Click here to see all  results for  Sorry, no results has been found matching your query.                   Adblocker Detected    Dear Valued Visitor, We have noticed that you are using an ad blocker software.
    Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages. To view this article, you can disable your ad blocker and refresh this page or simply login. We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.       Home > Hedge Funds > Camber Capital Management
				> Profile    Hedge Fund - Camber Capital Management  Get Email Alerts     Profile Holdings Latest 13D & 13G Filings News, Interviews, and Investor Letters     Get Email Alerts  Profile Holdings Latest 13D & 13G Filing News     Stephen Dubois Bio, Returns, Net Worth     Stephen DuBois's Camber Capital Management maintains a 13F portfolio of around $1 billion, and focuses on healthcare companies. Camber Capital Management is located in Boston and may be considered as an activist hedge fund because of a 2011 activist position in Conceptus Inc.                    Fund Profile  Filing Period:  2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31          Fund Name: Camber Capital Management   Manager Stephen Dubois   Portfolio Value $2,465,523,000   Change This QTR +1.28%                 Top Holdings  Login to See All Holdings | Sign up      Filing Period:  2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31     Last updated on May 15, 2017, 3:17 pm based on SEC 13F filings Last update: May 15, 2017, 3:17 pm              No.  Security  Ticker  Shares  Value (x$1000)  Activity  % Port      1. Spdr S & P 500 Etf TrustPUT SPY 3,000,000 $707,220  28.68%   2. Teva Pharmaceutical Inds Ltd TEVA 5,216,450 $167,396 +11% 6.78%   3. Mylan Nv  4,145,889 $161,648  6.55%   4. Gilead Sciences Inc GILD 1,900,000 $129,048 +27% 5.23%   5. Nektar Therapeutics NKTR 5,400,000 $126,738 -10% 5.14%        Login to See All Holdings | Sign up, It's FREE        Latest 13D & 13G Filings  Login to See All Filings | Sign up       Company Symbol Filed By Filing Date Filing    Amag Pharmaceuticals Inc. AMAG Camber Capital Management 2017-05-25 13G Filing   Amag Pharmaceuticals Inc. AMAG Camber Capital Management 2017-05-15 13G Filing   Cardiovascular Systems Inc CSII Camber Capital Management 2017-02-14 13G Filing   Epirus Biopharmaceuticals Inc. EPRS Camber Capital Management 2017-02-14 13G Filing       Login to See All Filings | Sign up, It's FREE       News, Interviews and Investor Letters See All         13G Filing: Camber Capital Management and Amag Pharmaceuticals Inc. (AMAG) ...... (read more) May 25th, 2017 -  Hedge Funds - Comments         13G Filing: Camber Capital Management and Amag Pharmaceuticals Inc. (AMAG) ...... (read more) May 15th, 2017 -  Hedge Funds - Comments         Ptc Therapeutics Inc. (PTCT): Camber Capital Management Adds 500,000 Shares to Its Position Stephen DuBois' Camber Capital Management recently filed a Form 13G with the SEC, in which it reported raising its stake in Ptc Therapeutics Inc. (NASDAQ:PTCT) to 2 million common shares, which represent...... (read more) September 30th, 2016 -  Hedge Funds News - Comments         Carl Icahn Can’t Stop Buying Cheniere; Nelson Peltz Boosts Stake In SYSCO Most individual investors already know the value of monitoring activist investors, who generally make value-enhancing proposals or push for changes at struggling companies in order to unlock shareholder...... (read more) December 11th, 2015 -  Commodities Hedge Funds News - Comments         Elite Hedge Funds’ Bullish Moves On These Four Stocks The latest round of 13F filings kicked off at the beginning of October, but as these public filings are only required to be filed within 45 days of the end of each calendar quarter, one might find their...... (read more) November 3rd, 2015 -  Hedge Fund Analysis Hedge Funds Market Movers News - Comments         Pfizer Inc (PFE) Made Protalix BioTherapeutics, Inc. (PLX) Jump 11% Today Camber Capital filed an amended 13G on Protalix BioTherapeutics (NYSE:PLX) today disclosing a large increase in its position. Stephen Dubois' hedge fund had 9 million shares of Protalix at the end of...... (read more) October 23rd, 2015 -  Hedge Funds News - Comments         Sequenom, Aclaris, and Xenoport Making Waves Among Elite Healthcare Investors Three prominent healthcare-focused funds that we track at Insider Monkey submitted filings with the SEC today, disclosing new or bulked up positions in three different healthcare stocks. Given their focus...... (read more) October 13th, 2015 -  Hedge Funds News - Comments         Camber Capital Quick To Move On This Newly-Listed Biotech Stock According to a recent filing with the Securities and Exchange Commission, Stephen DuBois's Camber Capital Management initiated a position in the newly-listed clinical-stage biopharmaceutical company,...... (read more) July 8th, 2015 -  Hedge Funds News - Comments         Healthcare-Focused Fund Camber Capital’s Top Picks: Masimo Corporation (MASI), The Medicines Company (MDCO) Camber Capital Management is a hedge fund headquartered in Boston and founded by Stephen DuBois. The hedge fund is considered as an activist due to activist position in Conceptus Inc. from 2011. In the...... (read more) June 23rd, 2015 -  Hedge Funds News - Comments         Epirus Biopharmaceuticals Inc (EPRS): These Two Funds Open New Positions The days of having no fund activity in Epirus Biopharmaceuticals Inc (NASDAQ:EPRS) are over. In filings with the SEC that were revealed over the last few days, both Stephen Dubois’s Camber Capital Management...... (read more) February 9th, 2015 -  Hedge Funds News - Comments         3 Stocks Hedge Funds Just Bought; Should You? We have a trifecta of recent hedge fund buying activity for you to digest, featuring three different funds and three different stocks. We’ll kick it off with Stephen DuBois’s Camber Capital Management...... (read more) February 4th, 2015 -  News - Comments         Masimo Corporation (MASI): Camber Capital Management Ups Passive Position to 5.5% Stephen DuBois' Camber Capital Management has reported raising its passive position in Masimo Corporation (NASDAQ:MASI). As a new filing with the Securities and Exchange Commission showed, Camber Capital...... (read more) November 10th, 2014 -  Hedge Funds News - Comments         Universal American Corporation (UAM): Camber Capital Management Resumes Buying Shares Stephen Dubois’ Camber Capital Management is again increasing its stakes in Universal American Corporation (NYSE:UAM). Camber Capital Management’s recent filing with the Securities and Exchange Commission...... (read more) October 20th, 2014 -  Hedge Funds News - Comments         Volcano Corporation (VOLC): Camber Capital Takes 9.81% Stake Stephen Dubois’ Camber Capital Management has disclosed in a regulatory filing with Security and Exchange Commission a stake of 9.81% in medical equipment company Volcano Corporation (NASDAQ:VOLC)....... (read more) October 2nd, 2014 -  Hedge Funds News - Comments         Orthofix International NV (OFIX): Stephen Dubois Surges His Stake Amid Company’s Financial Statements Issues As a new filing with the Securities and Exchange Commission showed, Camber Capital Management surged its exposure to Orthofix International NV (NASDAQ:OFIX). The fund managed by Stephen Dubois reported...... (read more) September 30th, 2014 -  Hedge Funds News - Comments       Click here to See All News           Hedge Fund Resource Center    How to Beat the Market by 20 Percentage Points Why Track Hedge Funds? Download a Free Edition! Why You Should DUMP Your Hedge Funds 6 Things You Didn't Know About Hedge Funds        Billionaire Hedge Funds          Warren Buffett Berkshire Hathaway $147,985,198,000          David Einhorn Greenlight Capital $5,818,885,000          George Soros Soros Fund Management $4,321,285,000          T Boone Pickens BP Capital $318,631,000          Jim Simons Renaissance Technologies $63,208,016,000          Leon Cooperman Omega Advisors $2,269,539,000          Carl Icahn Icahn Capital LP $22,373,522,000          Steve Cohen Point72 Asset Management $14,303,015,000          John Paulson Paulson & Co $7,934,312,000          David Tepper Appaloosa Management LP $5,640,040,000          Paul Tudor Jones Tudor Investment Corp $3,883,628,000          Stanley Druckenmiller Duquesne Capital $1,026,024,000          Julian Robertson Tiger Management $551,620,000          Ray Dalio Bridgewater Associates $10,528,018,000          Ken Fisher Fisher Asset Management $57,428,877,000          Bill Ackman Pershing Square $5,913,210,000          Edward Lampert ESL Investments $652,929,000          Dan Loeb Third Point $10,188,461,000          Ken Griffin Citadel Investment Group $99,007,951,000          Israel Englander Millennium Management $47,754,732,000          Michael Price MFP Investors $824,193,000              Home Hedge Funds Markets Blog Authors About Us Contact Us Privacy Policy Terms of Use Site Map  All text and design is copyright ©2016 Koala Guide LLC. All rights reserved.             





Bizapedia.com - Human Validation
















COMPANIESPEOPLEPRODUCTS/SERVICESTRADEMARKSADDRESSESPHONE BOOK




            Our system has detected a high number of page requests from your IP Address, please prove to us that you are a human to continue using our website.
        
























                            Please send me to the search subscription offer page after I successfully answer the word challenge.
                        









BIZAPEDIAPRO SEARCHPerform unlimited searches via ouradvanced search form withBizapedia Pro Search.FIND OUT MORE >BIZAPEDIAPRO DATABuild custom data listsfor one or many stateswith Bizapedia Pro Data.FIND OUT MORE >


Copyright © 2012-2017 · Bizapedia.com · All rights reserved.BlogPro SearchPro APIContact UsTerms of UsePrivacy PolicySitemapDesktop Version






























Term of Use | Camber Capital Management, LLC


Skip navigation

Camber Capital Management, LLC 





Term of Use



The material on this website contains confidential information and circulation or disclosure of all or any part of this material is prohibited.  The material on this web page neither constitutes an offer to sell nor a solicitation to invest in Camber Capital Fund, L.P., Camber Capital Fund II, L.P., Camber Capital Offshore Fund, Ltd. or Camber Capital Master Fund, L.P. (the “Funds”) managed by Camber Capital Management, LLC (the “Investment Manager”) or its affiliates.  Offers to sell or solicitations to invest in the Funds are made only by means of a confidential offering memorandum and in accordance with applicable securities laws.  
An investment in the Funds are suitable only for qualified investors that fully understand the risks of such an investment.  By accessing this website, you represent and warrant that you are an "accredited investor", as that term is defined in Regulation D under the Securities Act of 1933, as amended. An investor should review thoroughly with his, her or its advisors the appropriate Fund’s confidential offering memorandum before making an investment determination.  The Investment Manager is not acting as an financial adviser or otherwise making any recommendation as to an investor's decision to invest in the Funds.  
The material on this website has been prepared from original sources and data believed to be reliable.  However no representations are made as to the accuracy or completeness thereof.  An investment in the Funds involves a high degree of risk and is suitable only for sophisticated investors.  The information set forth herein is based on unaudited information as of the date provided.  The data has been sorted by certain categories (e.g. market cap and sector) based on the Investment Manager’s internal guidelines.  
There is no assurance that the Funds continue to own any of the positions identified herein.  As with any investment vehicle, past performance cannot assure any level of future results.  An investment in the Funds will be subject to a variety of risks (which are described in the Funds' confidential offering memorandum), and there can be no assurance that the Funds' investment objective will be met or that the Funds will not incur losses.







      By logging into this website, you agree to the terms and conditions of the Terms of Use

2017 © Camber Capital.















 Executive Team |  Camber Real Estate Partners LLC





 

























































    

























No menu assigned!











  





   
Executive Team
      




  




Christopher M. Bellapianta
Managing Principal
 









Christopher M. Bellapianta is the Managing Principal of Camber Real Estate Partners and is responsible for overseeing the firm’s operations, including financial, investment and partnership activities.  Chris is focused on sourcing, structuring and capitalizing investments for the firm including special situation debt and equity opportunities.
Prior to co-founding Camber Real Estate Partners, Chris was a Managing Director and Principal at Advance Realty where he led all acquisition and finance activities, acquiring over 3.1 million square feet and closing transactions with a total capitalization exceeding $650 million.  Prior to joining Advance, Chris served as Director of Acquisitions at Madison Capital, where he was part of a team that acquired performing and non-performing senior and subordinate debt on transactions with a total capitalization exceeding $425 million.
Previously, Chris oversaw portfolio-level underwriting and financing activities for Antares Investment Partners and served as Acquisitions Director for Atherton Newport Investments, where he was responsible for principal investments in East Coast Markets.  He began his career at Cushman & Wakefield, where he sourced, negotiated and closed leasing and sales transactions, primarily in New York City.
Chris is actively involved with several charitable, educational, civic and industry organizations. He resides in Hoboken, New Jersey with his family. Chris earned a Bachelor of Arts in Economics and a Bachelor of Science in Environmental Science from Hobart College. He also holds a Master of Science in Real Estate Development from Columbia University.  Chris is an avid skier and thoroughly enjoys cooking and music.





Dave C. Surti
Principal
  









As Principal of Camber Real Estate Partners, Dave C. Surti is responsible for overseeing the underwriting, due diligence, closing and asset management of the firm’s investments.
Prior to co-founding Camber Real Estate Partners, Dave was a Director at Advance Realty where he was integral in the execution of the firm’s acquisitions and capital markets transactions, and in facilitating asset management efforts.  Prior to Advance, Dave was with AREA Property Partners, LP, now a subsidiary of ARES Capital Management. There, he was responsible for portfolio-level analyses and investor relations for the firm’s opportunistic and value-add investment vehicles. These vehicles comprised $3.6 billion in equity capital invested on behalf of pension funds, university endowments, sovereign wealth funds and high-net-worth individuals.
Dave began his real estate career at NorthMarq Capital, LLC, where he executed on more than $1.0 billion in debt and equity transactions for commercial real estate assets. Previously, he served as a business technology analyst for Street Solutions, Inc., where he was involved in the development of residential mortgage-backed securities software solutions.
Dave graduated cum laude from the Leonard N. Stern School of Business at New York University with a Bachelor of Science in Finance. Dave resides in West Orange, New Jersey with his wife, Nina, and their son, Julian.





  




Learn More
Strategy Experience 














Contact UsAddress777 Passaic Avenue
Suite 385
Clifton, NJ 07012Phone(201) 258-5650Emailinfo@camberrep.com 


Follow UsLinkedIn







© 2017 Camber Real Estate Partners LLC.  














About
Strategy
Experience
Team
Investors


Contact UsAddress777 Passaic Avenue
Suite 385
Clifton, NJ 07012Phone(201) 258-5650Emailinfo@camberrep.comFollow UsLinkedIn


 

























